Ardent Health Inc Revenue Growth Rates (ARDT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ardent Health Inc   (NYSE: ARDT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ARDT's Revenue Growth by Quarter and Year

Ardent Health Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ARDT/growth
https://api.csimarket.com/api/v1/companies/ARDT/fundamentals
https://api.csimarket.com/api/v1/companies/ARDT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ARDT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,624.86
2nd Quarter June 1,622.25
1st Quarter March 1,601.87
FY 4,848.98





ARDT Revenue third quarter 2026 Y/Y Growth Comment
Ardent Health Inc achieved in the third quarter 2026, above Company average Revenue improvement of 3.05% year on year, to $ 1,624.86 millions.

Looking into third quarter 2026 results within Healthcare Facilities industry 31 other companies have achieved higher Revenue growth. While Ardent Health Inc ' s Revenue increase of 3.05% ranks overall at the positon no. 2887 in the third quarter 2026.


ARDT Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.05 %
2nd Quarter June -1.4 %
1st Quarter March 6.99 %
FY   -

Financial Statements
Ardent Health Inc 's third quarter 2026 Revenue $ 1,624.86 millions ARDT's Income Statement
Ardent Health Inc 's third quarter 2025 Revenue $ 1,576.75 millions Quarterly ARDT's Income Statement


ARDT Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.16 %
2nd Quarter June 1.27 %
1st Quarter March -0.2 %
FY (Year on Year)   -


Back to ARDT Growth rate Comparisons >> Back to ARDT Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #404
Overall #2887

Revenue Y/Y Growth Statistics
High Average Low
11.85 % 0.35 % -39.68 %
(Sep 30 2025)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #32
Healthcare Sector #404
Overall #2887
Revenue Y/Y Growth Statistics
High Average Low
11.85 % 0.35 % -39.68 %
(Sep 30 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Ardent Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
93.29 % 5.11 % -45.96 %
(Dec 31 2023)  


ARDT's III. Quarter Q/Q Revenue Comment
Ardent Health Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.16% quarter on quarter, to $ 1,624.86 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.17% in the III. Quarter a year ago.

Within Healthcare Facilities industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Ardent Health Inc 's Revenue growth quarter on quarter, overall rank is 1592.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #216
Overall #1592
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #216
Overall #1592
Revenue Q/Q Growth Statistics
High Average Low
93.29 % 5.11 % -45.96 %
(Dec 31 2023)  


ARDT's III. Quarter Q/Q Revenue Comment
Ardent Health Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.16% quarter on quarter, to $ 1,624.86 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.17% in the III. Quarter a year ago.

Within Healthcare Facilities industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Ardent Health Inc 's Revenue growth quarter on quarter, overall rank is 1592.


Ardent Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 6,405.94
Y / Y Revenue Growth (TTM) 3.34 %
Year on Year Revenue Growth Overall Ranking # 3241
Seqeuential Revenue Change (TTM) -0.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 2325


Cumulative Revenue growth Comment
Assuming the Ardent Health Inc 's fiscal year would have ended in Jun 30 2026, Ardent Health Inc would have reprted above average annual Revenue improvement of 3.34% year on year, of $ 6,406 millions.
This marks a slow-down of the companys growth trends and from the 6.72% growth in Mar 31 2026.

In the Healthcare sector 427 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1497 to 3241.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 428
Overall # 3241

Revenue TTM Y/Y Growth Statistics
High Average Low
6.72 %
 -2.79 %
-12.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 334
S&P 500 # 2325
Cumulative Revenue growth Comment
Assuming the Ardent Health Inc 's fiscal year would have ended in Jun 30 2026, Ardent Health Inc would have reprted above average annual Revenue improvement of 3.34% year on year, of $ 6,406 millions.
This marks a slow-down of the companys growth trends and from the 6.72% growth in Mar 31 2026.

In the Healthcare sector 427 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1497 to 3241.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 428
Overall # 3241

Revenue TTM Y/Y Growth Statistics
High Average Low
6.72 %
-2.79 %
-12.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 334
S&P 500 # 2325




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARDT's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Universal Health Services Inc 5.30%$ 5.297 millions
Acadia Healthcare Company Inc 5.14%$ 5.136 millions
Lumexa Imaging Holdings Inc 5.03%$ 5.032 millions
Bio techne Corp4.75%$ 4.753 millions
Merck and Co Inc 4.68%$ 4.683 millions
Davita Inc 4.62%$ 4.617 millions
Sotera Health Company4.61%$ 4.613 millions
Avantor Inc 4.59%$ 4.588 millions
Icu Medical Inc4.39%$ 4.388 millions
Illumina Inc 4.15%$ 4.151 millions
Agenus Inc4.14%$ 4.144 millions
United Therapeutics Corporation4.13%$ 4.128 millions
Option Care Health Inc 4.09%$ 4.086 millions
Henry Schein Inc 3.95%$ 3.953 millions
Grail Inc 3.71%$ 3.705 millions
Docgo Inc 3.70%$ 3.702 millions
Hca Healthcare Inc 3.59%$ 3.591 millions
Collegium Pharmaceutical Inc 3.43%$ 3.427 millions
Healthcare Services Group Inc 3.29%$ 3.288 millions
Cytek Biosciences Inc 3.26%$ 3.255 millions
Zimmer Biomet Holdings Inc 3.07%$ 3.073 millions
Ardent Health Inc 3.05%$ 3.051 millions
Bioventus Inc 3.05%$ 3.048 millions
Infusystem Holdings Inc3.02%$ 3.017 millions
Integra Lifesciences Holdings Corp2.27%$ 2.268 millions
Align Technology inc 1.97%$ 1.966 millions
Pediatrix Medical Group Inc 1.72%$ 1.724 millions
Lantheus Holdings Inc 1.71%$ 1.708 millions
10x Genomics Inc 1.59%$ 1.591 millions
Bruker Corporation1.58%$ 1.581 millions


About Ardent Health Inc Revenue Growth Rates (ARDT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Ardent Health Inc (CIK 1756655).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-071073
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Ardent Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.